New antivirals for the treatment of chronic hepatitis B.
about
Baracle® vs Baraclude® for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety.Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.Viral Biomarkers in Chronic HBeAg Negative HBV Infection
P2860
New antivirals for the treatment of chronic hepatitis B.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
New antivirals for the treatment of chronic hepatitis B.
@en
New antivirals for the treatment of chronic hepatitis B.
@nl
type
label
New antivirals for the treatment of chronic hepatitis B.
@en
New antivirals for the treatment of chronic hepatitis B.
@nl
prefLabel
New antivirals for the treatment of chronic hepatitis B.
@en
New antivirals for the treatment of chronic hepatitis B.
@nl
P2093
P2860
P1476
New antivirals for the treatment of chronic hepatitis B.
@en
P2093
Carmen de Mendoza
Jose M Peña
Laura Benitez
Pablo Barreiro
P2860
P304
P356
10.1080/13543784.2017.1333105
P407
P577
2017-05-18T00:00:00Z